Latest Breaking News On - Liposomal annamycin - Page 1 : comparemela.com

Moleculin Announces U S Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin

Moleculin Announces U S Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of texasJenene thomasLiposomal annamycinWalter klempPrnewswire moleculin biotech incSecurities exchangeUniversity of texas system board regentsExchange commissionMoleculin biotech incTrademark officeIssue notificationUnited states patentReconstituting liposomalTexas system boardInstitutional conflict

Moleculin Biotech (MBRX) presents positive Phase 1B/2 clinical trial evaluating Annamycin

Moleculin Biotech (MBRX) presents positive Phase 1B/2 clinical trial evaluating Annamycin
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Liposomal annamycinWalter klempBrian andrew vanMoleculin biotech incWashington university school of medicineDrug administrationMoleculin biotechPreviously treated soft tissue sarcomasPulmonary metastasesAndrew van tineWashington university schoolChief executive officerFast track statusOrphan drug designation

Moleculin Reports Second Quarter 2023 Financial Results

/PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a growing pipeline,.

United kingdomUnited statesLiposomal annamycinWalter klempJenene thomasExchange commissionMoleculin biotech incPrnewswire moleculin biotech incSecurities exchangeShareholder intelligence servicesBritish journal of cancer researchReleased clinical trial updateChief executive officerMoleculin provides updateOngoing clinical trialsOutlines expected upcoming milestones

Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones

– Announces successful completion of the Phase 1B portion of its Phase 1B/2 clinical trial Annamycin in combination with Cytarabine for the treatment of AML.

United kingdomUnited statesTacaribe arenavirusJenene thomasLiposomal annamycinWalter klempEuropean unionBritish journal of cancer researchNational institutes of healthMoleculin biotech incDrug administrationExchange commissionSecurities exchangeCompany core technologiesNorthwestern universityMoleculin biotech

Moleculin Biotech (MBRX) Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones

Moleculin Biotech (MBRX) Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomWalter klempTacaribe arenavirusLiposomal annamycinCompany core technologiesBritish journal of cancer researchNational institutes of healthEuropean unionDrug administrationMoleculin biotech incNorthwestern universityMoleculin biotechChief executive officerGeneration anthracyclineRecommended phaseAfter induction therapy